South San Francisco, California–based biopharma CODA Biotherapeutics names Susan Catalano as chief scientific officer. Founded in 2014, CODA Biotherapeutics is working on a gene therapy-mediated chemogenetic platform for intractable neurological disorders. Catalano aims to help advance the company’s platform to find treatments for unmet neurological needs. “CODA’s combination of deep expertise in gene therapy and…